Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Tap water linked to potential risks | New cardiac care certification announced | FDA clears AI software | Post-stroke injections
Friday, January 30, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Tap water in US linked to potential cardiovascular risks

“This is not about alarming people,” one researcher said. “It’s about recognizing an environmental factor that may be contributing to high blood pressure in some communities and making sure it’s part of the public health conversation." 

READ MORE >
fasting before tavr or ablation
Share on Twitter Share on Facebook Share on Linkedin

Tap water in US linked to potential cardiovascular risks

Share on Twitter Share on Facebook Share on Linkedin
fasting before tavr or ablation
“This is not about alarming people,” one researcher said. “It’s about recognizing an environmental factor that may be contributing to high blood pressure in some communities and making sure it’s part of the public health conversation." 
READ MORE >

Joint Commission partners with STS, ACC on new cardiac care certification

The new certification is focused on the importance of high-quality care and real-world patient outcomes. It will be based on the same data care teams already submit if they participate in the STS Adult Cardiac Surgery Database, ACC CathPCI Registry or STS/ACC TVT Registry.

READ MORE >
cardiologists heart doctors
Share on Twitter Share on Facebook Share on Linkedin

Joint Commission partners with STS, ACC on new cardiac care certification

Share on Twitter Share on Facebook Share on Linkedin
cardiologists heart doctors
The new certification is focused on the importance of high-quality care and real-world patient outcomes. It will be based on the same data care teams already submit if they participate in the STS Adult Cardiac Surgery Database, ACC CathPCI Registry or STS/ACC TVT Registry.
READ MORE >

FDA clears AI software for heart murmur detection with digital stethoscopes

eMurmer's new Heart AI software was designed to detect both the presence and absence of heart murmurs in digital stethoscope recordings. It can also gather critical hemodynamic data, helping care teams gain a better understanding of the patient's cardiovascular health. 

READ MORE >
eMurmur Heart AI
Share on Twitter Share on Facebook Share on Linkedin

FDA clears AI software for heart murmur detection with digital stethoscopes

Share on Twitter Share on Facebook Share on Linkedin
eMurmur Heart AI
eMurmer's new Heart AI software was designed to detect both the presence and absence of heart murmurs in digital stethoscope recordings. It can also gather critical hemodynamic data, helping care teams gain a better understanding of the patient's cardiovascular health. 
READ MORE >

New injectable therapy could help limit brain damage in stroke patients

Early research suggests a single injection could reduce both brain damage and inflammation if delivered after a patient experiences a stroke. Much more research is still needed, but the new therapy showed significant potential. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New injectable therapy could help limit brain damage in stroke patients

Share on Twitter Share on Facebook Share on Linkedin
Early research suggests a single injection could reduce both brain damage and inflammation if delivered after a patient experiences a stroke. Much more research is still needed, but the new therapy showed significant potential. 
READ MORE >

Featured Articles

TMVR device with valve-in-ring design gains key approval

HighLife's new-look TMVR technology was designed to treat a wide range of patients. The two-part implant process includes a ring and a valve that centers itself inside that ring.

READ MORE >
HighLife Transcatheter Mitral Valve Replacement (TMVR) System
Share on Twitter Share on Facebook Share on Linkedin

TMVR device with valve-in-ring design gains key approval

Share on Twitter Share on Facebook Share on Linkedin
HighLife Transcatheter Mitral Valve Replacement (TMVR) System
HighLife's new-look TMVR technology was designed to treat a wide range of patients. The two-part implant process includes a ring and a valve that centers itself inside that ring.
READ MORE >

ASNC says PET is now the preferred nuclear imaging test for CAD

Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.

READ MORE >
Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
Share on Twitter Share on Facebook Share on Linkedin

ASNC says PET is now the preferred nuclear imaging test for CAD

Share on Twitter Share on Facebook Share on Linkedin
Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.
READ MORE >

Cardiologist highlights key differences between OBLs and ASCs

Current payment policies have health systems and physicians all over the country looking to learn more about these two business models. 

READ MORE >
Samir B. Pancholy, MD, chief interventional cardiologist, Wayne Memorial Hospital in Honesdale, Pennsylvania, discusses the differences in the business models for office based labs (OBL) vs ambulatory surgical centers (ASC) and choosing the right model cardiovascular and vascular procedures. #TCT #SCAI #OBL #ASC
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist highlights key differences between OBLs and ASCs

Share on Twitter Share on Facebook Share on Linkedin
Samir B. Pancholy, MD, chief interventional cardiologist, Wayne Memorial Hospital in Honesdale, Pennsylvania, discusses the differences in the business models for office based labs (OBL) vs ambulatory surgical centers (ASC) and choosing the right model cardiovascular and vascular procedures. #TCT #SCAI #OBL #ASC
Current payment policies have health systems and physicians all over the country looking to learn more about these two business models. 
READ MORE >

Patients with paradoxical low-flow, low gradient AS linked to higher mortality rate after TAVR

Patients with this specific subtype of severe aortic stenosis, which can sometimes be challenging to diagnose, face a number of additional risks.

READ MORE >
old woman or doctor shaking hands with patient
Share on Twitter Share on Facebook Share on Linkedin

Patients with paradoxical low-flow, low gradient AS linked to higher mortality rate after TAVR

Share on Twitter Share on Facebook Share on Linkedin
old woman or doctor shaking hands with patient
Patients with this specific subtype of severe aortic stenosis, which can sometimes be challenging to diagnose, face a number of additional risks.
READ MORE >

Heart failure patients on quadruple medical therapy still face considerable risks

Most patients hospitalized for HFrEF are still not being prescribed quadruple medical therapy at discharge. Even those who are, researchers noted, still face a high risk of dying or returning to the hospital for heart failure-related symptoms. 

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Heart failure patients on quadruple medical therapy still face considerable risks

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
Most patients hospitalized for HFrEF are still not being prescribed quadruple medical therapy at discharge. Even those who are, researchers noted, still face a high risk of dying or returning to the hospital for heart failure-related symptoms. 
READ MORE >

In Case You Missed It

FDA clears Medtronic’s new smart diabetes management app

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

READ MORE >
Medtronic has received U.S. Food and Drug Administration (FDA) clearance for the MiniMed Go Smart Multiple Daily Injection system.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears Medtronic’s new smart diabetes management app

Share on Twitter Share on Facebook Share on Linkedin
Medtronic has received U.S. Food and Drug Administration (FDA) clearance for the MiniMed Go Smart Multiple Daily Injection system.
Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.
READ MORE >

Bayer expands into molecular imaging with cardiac amyloidosis tracer acquisitions

Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis.

READ MORE >
PET-CT imaging of 124-I evuzamitide and SPECT-CT imaging of 99mTc-p5+14 showed radiotracer uptake in both AL and ATTR amyloid throughout the myocardium. Emily B. Martin, Anne Kassira, Alan Stuckey, et al. A tale of two tracers - Amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05). https://www.journalofnuclearcardiology.org/article/S1071-3581(25)00325-3/abstract.
Share on Twitter Share on Facebook Share on Linkedin

Bayer expands into molecular imaging with cardiac amyloidosis tracer acquisitions

Share on Twitter Share on Facebook Share on Linkedin
PET-CT imaging of 124-I evuzamitide and SPECT-CT imaging of 99mTc-p5+14 showed radiotracer uptake in both AL and ATTR amyloid throughout the myocardium. Emily B. Martin, Anne Kassira, Alan Stuckey, et al. A tale of two tracers - Amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05). https://www.journalofnuclearcardiology.org/article/S1071-3581(25)00325-3/abstract.
Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis.
READ MORE >

Same-day discharge after PCI for NSTE-ACS is on the rise

Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.

READ MORE >
Sunil Rao, MD, MSCAI, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, explains the prevalence, trends and predictors of same day discharge after percutaneous coronary intervention (PCI) data for non-ST-elevation acute coronary syndrome (NSTE-ACS) in clinical practice from the NCDR-CathPCI Registry.
Share on Twitter Share on Facebook Share on Linkedin

Same-day discharge after PCI for NSTE-ACS is on the rise

Share on Twitter Share on Facebook Share on Linkedin
Sunil Rao, MD, MSCAI, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, explains the prevalence, trends and predictors of same day discharge after percutaneous coronary intervention (PCI) data for non-ST-elevation acute coronary syndrome (NSTE-ACS) in clinical practice from the NCDR-CathPCI Registry.
Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.
READ MORE >

In Other News

Express Scripts considering settlement with FTC to resolve insulin pricing dispute, filing reveals

The Federal Trade Commission said it's seeking a resolution with Cigna, the parent company of the pharmacy benefit manager. The agency filed an antitrust complaint against Express Scripts, Optum Rx and CVS Caremark in 2024, alleging the "Big Three" PBMs use anticompetitive tactics to control the insulin supply chain within their vertical.

READ MORE >
Federal Trade Comission FTC Sign logo
Share on Twitter Share on Facebook Share on Linkedin

Express Scripts considering settlement with FTC to resolve insulin pricing dispute, filing reveals

Share on Twitter Share on Facebook Share on Linkedin
Federal Trade Comission FTC Sign logo
The Federal Trade Commission said it's seeking a resolution with Cigna, the parent company of the pharmacy benefit manager. The agency filed an antitrust complaint against Express Scripts, Optum Rx and CVS Caremark in 2024, alleging the "Big Three" PBMs use anticompetitive tactics to control the insulin supply chain within their vertical.
READ MORE >

Overconfident patients, underconfident nurses, pilot failures & more AI briefings

More than 75% of U.S. nurses have high hopes in generative AI’s promise for improving productivity. But less than half feel prepared to use it effectively. Never mind that almost 60% use it in their personal lives. 

READ MORE >
Nurse
Share on Twitter Share on Facebook Share on Linkedin

Overconfident patients, underconfident nurses, pilot failures & more AI briefings

Share on Twitter Share on Facebook Share on Linkedin
Nurse
More than 75% of U.S. nurses have high hopes in generative AI’s promise for improving productivity. But less than half feel prepared to use it effectively. Never mind that almost 60% use it in their personal lives. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup